Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

LncRNA DLX6-AS1 as a potential molecular biomarker in the clinicopathology and prognosis of various cancers: a meta-analysis.

Bioscience reports - 28 Aug 2020

Tian Shubo, Liu Jinglei, Kong Shuai, Peng Lipan

Abstract excerpt

OBJECTIVE: Recent studies have shown that distal-less homeobox 6 antisense 1 (DLX6-AS1) is aberrantly expressed in various cancers and is associated with poor prognosis. This meta-analysis is designed to investigate the effects of DLX6-AS1 expression on clinicopathological features and survival outcomes. METHODS: All eligible studies were searched from Pubmed, Web of Science, Embase, the Cochrane Library, and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasms

Share to Phenotype

Share to Prognosis

Share to Risk Assessment

Share to Risk Factors

Share to RNA, Long Noncoding

Source

Open in PubMed Open full text

Identifiers

PMID: 32785606
DOI: 10.1042/BSR20193532
PMCID: PMC7447853

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

LncRNA DLX6-AS1 as a potential molecular biomarker in the clinicopathology and prognosis of various cancers: a meta-analysis.PMID 32785606Read ↗

Clinicopathological and Prognostic Value of SNHG6 in Cancers: a Systematic Review and a Meta-analysisSemantic proximity Read ↗

IncRNA VIM-AS1 expression is positively correlated with the prognosis and immune infiltration in lung adenocarcinomaSemantic proximity Read ↗

lncRNA CERS6-AS1 promotes cell proliferation, migration, invasion, and epithelial-mesenchymal transformation of lung adenocarcinoma by sponging miR-424-5p upregulates ANLN expressionSemantic proximity Read ↗

Current Research Progress of the Role of LncRNA LEF1-AS1 in a Variety of TumorsSemantic proximity Read ↗

The role of long non-coding RNA FGD5-AS1 in cancerSemantic proximity Read ↗

Prognostic Value of Long Noncoding RNA NORAD in Various cancers: a meta-analysisSemantic proximity Read ↗

A promising new cancer marker: Long noncoding RNA EGFR-AS1Semantic proximity Read ↗

LncRNA DLX6-AS1 increases the expression of HIF-1α and promotes the malignant phenotypes of nasopharyngeal carcinoma cells via targeting MiR-199a-5p.Semantic proximity Read ↗

Upregulated expression of MNX1-AS1 long noncoding RNA predicts poor prognosis in gastric cancerSemantic proximity Read ↗

FXYD6 Functions as a Tumor Suppressor in Lung Adenocarcinoma via the OIP5-AS1/miR-4735-3p/FXYD6 AxisSemantic proximity Read ↗

Clinicopathological and prognostic significance of long noncoding RNA MALAT1 in human cancers: a review and meta-analysisSemantic proximity Read ↗

Unveiling Novel Regulatory Mechanisms of BEX1 in Breast, Gastric, and Colorectal Cancer via a Systems Biology Approach: The Roles of lncRNAs COLCA1 and GAS6-AS1 and Their InteractionsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.